SMPDL3b modulates insulin receptor signaling in diabetic kidney disease
Sphingomyelin phosphodiesterase acid-like 3b (SMPDL3b) is a lipid raft enzyme known to affect membrane lipid composition. Here, Mitrofanova et al. show that increased expression of SMPDL3b in diabetes impairs insulin signaling and ceramide-1-phosphate (C1P) availability in podocytes, and that C1P su...
Main Authors: | A. Mitrofanova, S. K. Mallela, G. M. Ducasa, T. H. Yoo, E. Rosenfeld-Gur, I. D. Zelnik, J. Molina, J. Varona Santos, M. Ge, A. Sloan, J. J. Kim, C. Pedigo, J. Bryn, I. Volosenco, C. Faul, Y. H. Zeidan, C. Garcia Hernandez, A. J. Mendez, I. Leibiger, G. W. Burke, A. H. Futerman, L. Barisoni, Y. Ishimoto, R. Inagi, S. Merscher, A. Fornoni |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2019-06-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-019-10584-4 |
Similar Items
-
Crosstalk Between SMPDL3b and NADPH Oxidases Mediates Radiation-Induced Damage of Renal Podocytes
by: Patrick Azzam, et al.
Published: (2021-09-01) -
The Lipid-Modifying Enzyme SMPDL3B Negatively Regulates Innate Immunity
by: Leonhard X. Heinz, et al.
Published: (2015-06-01) -
SMPDL3B Predicts Poor Prognosis and Contributes to Development of Acute Myeloid Leukemia
by: Huiqing Qu, et al.
Published: (2021-08-01) -
Metabolism, energetics, and lipid biology in the podocyte – Cellular cholesterol mediated glomerular injury
by: Sandra eMerscher, et al.
Published: (2014-10-01) -
Phosphodiesterase <i>SMPDL3B</i> Gene Expression as Independent Outcome Prediction Marker in Localized Prostate Cancer
by: Frank Waldbillig, et al.
Published: (2020-06-01)